Kim Isaacs

Summary

Affiliation: University of North Carolina
Country: USA

Publications

  1. ncbi request reprint Upper gastrointestinal tract endoscopy in inflammatory bowel disease
    Kim L Isaacs
    Division of Digestive Diseases and Nutrition, University of North Carolina School of Medicine, CB 7080, Room 3034B, Old Clinic Building, Chapel Hill, NC 27599 7080, USA
    Gastrointest Endosc Clin N Am 12:451-62, vii. 2002
  2. doi request reprint Fistula treatment: The unresolved challenge
    Stephan R Vavricka
    Division of Gastroenterology and Hepatology, Department of Internal Medicine, University Hospital Zurich, Zurich, Switzerland
    Dig Dis 28:556-64. 2010
  3. doi request reprint How rapidly should remission be achieved?
    Kim L Isaacs
    Division of Gastroenterology and Hepatology, University of North Carolina, Chapel Hill, NC 27599 7032, USA
    Dig Dis 28:548-55. 2010
  4. doi request reprint Role of probiotic therapy in IBD
    Kim Isaacs
    University of North Carolina at Chapel Hill, Division of Gastroenterology and Hepatology, Chapel Hill, NC 27599 7032, USA
    Inflamm Bowel Dis 14:1597-605. 2008
  5. ncbi request reprint Rifaximin for the treatment of active pouchitis: a randomized, double-blind, placebo-controlled pilot study
    Kim L Isaacs
    University of North Carolina, Chapel Hill, North Carolina 27599 7032, USA
    Inflamm Bowel Dis 13:1250-5. 2007
  6. ncbi request reprint Treatment of inflammatory bowel disease with antibiotics
    Kim L Isaacs
    Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina at Chapel Hill, 27599 7080, USA
    Gastroenterol Clin North Am 33:335-45, x. 2004
  7. pmc Impact of capsule endoscopy on management of inflammatory bowel disease: a single tertiary care center experience
    Millie D Long
    University of North Carolina at Chapel Hill, Division of Gastroenterology and Hepatology, Chapel Hill, North Carolina 27599 7080, USA
    Inflamm Bowel Dis 17:1855-62. 2011
  8. pmc A randomized, controlled, double-blind trial of air insufflation versus carbon dioxide insufflation during ERCP
    Evan S Dellon
    Center for Gastrointestinal Biology and Disease, Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599 7080, USA
    Gastrointest Endosc 72:68-77. 2010
  9. pmc Efficacy of methotrexate in ulcerative colitis: failure or promise
    Hans H Herfarth
    Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina, Chapel Hill, North Carolina 27599, USA
    Inflamm Bowel Dis 16:1421-30. 2010
  10. ncbi request reprint Crohn's disease of the esophagus
    Kim L Isaacs
    Kim L Isaacs, MD, PhD Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, CB 7032, Room 7200 MBRB, Chapel Hill, NC 27599 7032, USA
    Curr Treat Options Gastroenterol 10:61-70. 2007

Detail Information

Publications15

  1. ncbi request reprint Upper gastrointestinal tract endoscopy in inflammatory bowel disease
    Kim L Isaacs
    Division of Digestive Diseases and Nutrition, University of North Carolina School of Medicine, CB 7080, Room 3034B, Old Clinic Building, Chapel Hill, NC 27599 7080, USA
    Gastrointest Endosc Clin N Am 12:451-62, vii. 2002
    ..Upper gastrointestinal endoscopy may allow for therapeutic intervention in terms of bleeding and stricturing disease...
  2. doi request reprint Fistula treatment: The unresolved challenge
    Stephan R Vavricka
    Division of Gastroenterology and Hepatology, Department of Internal Medicine, University Hospital Zurich, Zurich, Switzerland
    Dig Dis 28:556-64. 2010
    ..The unresolved challenges in fistula treatment warrant randomized controlled trials for existing and future treatment strategies as well as a better classification system to compare available studies...
  3. doi request reprint How rapidly should remission be achieved?
    Kim L Isaacs
    Division of Gastroenterology and Hepatology, University of North Carolina, Chapel Hill, NC 27599 7032, USA
    Dig Dis 28:548-55. 2010
    ..In this presentation induction of clinical remission and mucosal healing in Crohn's disease and ulcerative colitis will be discussed. The impact of early remission on disease course will also be reviewed...
  4. doi request reprint Role of probiotic therapy in IBD
    Kim Isaacs
    University of North Carolina at Chapel Hill, Division of Gastroenterology and Hepatology, Chapel Hill, NC 27599 7032, USA
    Inflamm Bowel Dis 14:1597-605. 2008
    ..This review examines the data of all fully published articles currently available for the role of probiotics in the treatment of IBD...
  5. ncbi request reprint Rifaximin for the treatment of active pouchitis: a randomized, double-blind, placebo-controlled pilot study
    Kim L Isaacs
    University of North Carolina, Chapel Hill, North Carolina 27599 7032, USA
    Inflamm Bowel Dis 13:1250-5. 2007
    ..The efficacy of the nonabsorbable antibiotic rifaximin in patients with active acute or chronic pouchitis is unknown...
  6. ncbi request reprint Treatment of inflammatory bowel disease with antibiotics
    Kim L Isaacs
    Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina at Chapel Hill, 27599 7080, USA
    Gastroenterol Clin North Am 33:335-45, x. 2004
    ..This article summarizes published studies of antibiotics in IBD patients and reviews available data for the use of antibiotic therapy in Crohn's disease and ulcerative colitis...
  7. pmc Impact of capsule endoscopy on management of inflammatory bowel disease: a single tertiary care center experience
    Millie D Long
    University of North Carolina at Chapel Hill, Division of Gastroenterology and Hepatology, Chapel Hill, North Carolina 27599 7080, USA
    Inflamm Bowel Dis 17:1855-62. 2011
    ..Capsule endoscopy (CE) is performed to assess inflammatory bowel disease (IBD). We aimed to define the results of CE in subtypes of IBD and to determine whether CE results in management changes...
  8. pmc A randomized, controlled, double-blind trial of air insufflation versus carbon dioxide insufflation during ERCP
    Evan S Dellon
    Center for Gastrointestinal Biology and Disease, Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599 7080, USA
    Gastrointest Endosc 72:68-77. 2010
    ..Carbon dioxide (CO(2)) insufflation decreases postprocedure abdominal discomfort and distension after colonoscopy, but there have been few published studies on its use in ERCP...
  9. pmc Efficacy of methotrexate in ulcerative colitis: failure or promise
    Hans H Herfarth
    Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina, Chapel Hill, North Carolina 27599, USA
    Inflamm Bowel Dis 16:1421-30. 2010
    ....
  10. ncbi request reprint Crohn's disease of the esophagus
    Kim L Isaacs
    Kim L Isaacs, MD, PhD Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, CB 7032, Room 7200 MBRB, Chapel Hill, NC 27599 7032, USA
    Curr Treat Options Gastroenterol 10:61-70. 2007
    ..Surgery may be required for severe, refractory symptoms, but it has a high morbidity in this population...
  11. ncbi request reprint State of the art: IBD therapy and clinical trials in IBD
    Kim L Isaacs
    University of North Carolina, Chapel Hill, North Carolina, USA
    Inflamm Bowel Dis 11:S3-12. 2005
    ..The number of products under development and continued investigations into the pathogenesis of IBD emphasize the need to expand clinical research efforts in IBD...
  12. pmc NOD2 mutations and anti-Saccharomyces cerevisiae antibodies are risk factors for Crohn's disease in African Americans
    Themistocles Dassopoulos
    Gastroenterology Division, Department of Medicine, The Harvey M and Lyn P Meyerhoff Inflammatory Bowel Disease Center, Johns Hopkins University School of Medicine, Baltimore, Maryland 21231, USA
    Am J Gastroenterol 105:378-86. 2010
    ..NOD2 mutations and anti-Saccharomyces cerevisiae antibodies (ASCAs) are established risk factors of Crohn's disease (CD) in whites but have not been assessed in African-American (AA) adults with CD...
  13. ncbi request reprint Design issues and outcomes in IBD clinical trials
    Bruce E Sands
    Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA
    Inflamm Bowel Dis 11:S22-8. 2005
    ..Careful subject selection, standardization of disease activity indices, and precise outcome measurement are the keys to continued improvement of the inflammatory bowel disease research process...
  14. ncbi request reprint Tacrolimus for the treatment of fistulas in patients with Crohn's disease: a randomized, placebo-controlled trial
    William J Sandborn
    Mayo Clinic, 200 First Street Southwest, Rochester, Minnesota 55905, USA
    Gastroenterology 125:380-8. 2003
    ..This study determined the effectiveness of tacrolimus for the treatment of Crohn's disease fistulas...
  15. ncbi request reprint A randomized, placebo-controlled, phase II study of tetomilast in active ulcerative colitis
    Stefan Schreiber
    Department of General Internal Medicine, Christian Albrechts University, Schittenhelmstrasse 12, Kiel Schleswig Holstein 24105, Germany
    Gastroenterology 132:76-86. 2007
    ..Tetomilast (OPC-6535), a novel thiazole compound, inhibits phosphodiesterase-4 and proinflammatory functions of leukocytes including superoxide production and cytokine release...